Literature DB >> 25552583

The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.

K E R Gooijert1, R Havinga1, H Wolters1, R Wang2, V Ling2, S Tazuma3, H J Verkade4.   

Abstract

Human bile salt export pump (BSEP) mutations underlie progressive familial intrahepatic cholestasis type 2 (PFIC2). In the PFIC2 animal model, Bsep(-/-) mice, biliary secretion of bile salts (BS) is decreased, but that of phospholipids (PL) and cholesterol (CH) is increased. Under physiological conditions, the biliary secretion of PL and CH is positively related ("coupled") to that of BS. We aimed to elucidate the mechanism of increased biliary lipid secretion in Bsep(-/-) mice. The secretion of the BS tauro-β-muricholic acid (TβMCA) is relatively preserved in Bsep(-/-) mice. We infused Bsep(-/-) and Bsep(+/+) (control) mice with TβMCA in stepwise increasing dosages (150-600 nmol/min) and determined biliary bile flow, BS, PL, and CH secretion. mRNA and protein expression of relevant canalicular transporters was analyzed in livers from noninfused Bsep(-/-) and control mice. TβMCA infusion increased BS secretion in both Bsep(-/-) and control mice. The secreted PL or CH amount per BS, i.e., the "coupling," was continuously two- to threefold higher in Bsep(-/-) mice (P < 0.05). Hepatic mRNA expression of canalicular lipid transporters Mdr2, Abcg5, and Abcg8 was 45-55% higher in Bsep(-/-) mice (Abcg5; P < 0.05), as was canalicular Mdr2 and Abcg5 protein expression. Potential other explanations for the increased coupling of the biliary secretion of PL and CH to that of BS in Bsep(-/-) mice could be excluded. We conclude that the mechanism of increased biliary lipid secretion in Bsep(-/-) mice is based on increased expression of the responsible canalicular transporter proteins.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  bile salt export pump (Bsep); canalicular lipid transporters; cholesterol; phospholipid; tauro-β-muricholate

Mesh:

Substances:

Year:  2014        PMID: 25552583     DOI: 10.1152/ajpgi.00391.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  5 in total

Review 1.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

Review 2.  Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles.

Authors:  Boyan Zhang; Folkert Kuipers; Jan Freark de Boer; Jan Albert Kuivenhoven
Journal:  J Clin Med       Date:  2021-12-21       Impact factor: 4.241

3.  Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effects.

Authors:  Claudia D Fuchs; Emmanuel D Dixon; Tim Hendrikx; Veronika Mlitz; Annika Wahlström; Marcus Ståhlman; Hubert Scharnagl; Tatjana Stojakovic; Christoph J Binder; Hanns-Ulrich Marschall; Michael Trauner
Journal:  Hepatol Commun       Date:  2022-06-12

4.  Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota.

Authors:  Qian Zhuang; Xin Ye; Shuang Shen; Jinnian Cheng; Yan Shi; Shan Wu; Jie Xia; Min Ning; Zhixia Dong; Xinjian Wan
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

Review 5.  Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5ABCG8.

Authors:  Kori Williams; Allison Segard; Gregory A Graf
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.